A host of rehabilitative technology companies are entering the Asian market in force, driven by the needs of the region’s aging population for exercise and rehab equipment to combat immobility, muscular atrophy, and the epidemics of heart disease, hypertension, stroke, osteoarthritis, and... Read More
Three years after China launched a national drug bulk-buying program to negotiate lower prices from drug manufacturers, competitive pressure continues to grow on multinational pharmaceutical companies seeking to compete in the vast country’s market. The results of the fourth round of the... Read More
Cancer is a high priority in China. Incidence rates are rising quickly with lung, colorectal, stomach, liver, and breast being the most numerous. China’s local biotech companies are now focusing on cancer especially R&D in immune-oncology and cell therapies. More China biotechs... Read More
China, Korea, Taiwan, and Japan are rapidly becoming world leaders in cell and gene therapy research and innovation, fueled by significant public and private investment and streamlined regulations that are spurring breakthroughs in the field. All three countries have long been leaders... Read More
This article was originally published on MedTech Intelligence. With patients and medical providers across Asia and around the world forced by the global pandemic to rely on online platforms more than ever before, the medical device industry is finding itself uniquely vulnerable... Read More
Sales of diagnostic mammography equipment in the Asia-Pacific region is expected to rise significantly over the next eight years, according to two recently published studies. The reports by Globalcan and GlobalData vary in their specific findings. But both project compound annual growth... Read More
Radio Frequency Identification (RFID), a fast-developing technology that uses radio waves to collect and transfer data, is increasingly being adopted in healthcare markets across the Asia Pacific region and around the globe. A study by Precedence Research found sales of the technology,... Read More
With the COVID-19 pandemic bringing into focus the need for better collection and use of data in healthcare, health authorities in Vietnam are pushing to accelerate the development of artificial intelligence platform and technologies. In June, the Ministry of Health announced an... Read More
Western investors are increasingly investing in Chinese biotechnology firms, driven by a surge in demand for cutting edge treatments for the novel coronavirus and other new therapies being developed in China. Over the past five years, Chinese firms have moved away from... Read More
This article was originally published on Medtech Intelligence Fueled by an urgent need for diagnostic testing to respond to the COVID-19 pandemic, the in-vitro diagnostics (IVD) market is experiencing explosive growth across Asia and around the globe. Already expanding for the past... Read More